Tuteja Lab, Iowa State University, Ames IA-50011
The HTML version of this documentation is available here:
- Section 1: Preparing datasets for anlayses
- Section 2: DESeq2 analyses
- Section 3: PCA plots for the datasets
- Section 4: Finding novel amnion markers
- Section 5: sn/scRNAseq data analyses
- Section 6: Custom encrichment dataset preparation
The data used in this study are publicly available:
BioProject | Assay Type | source_name | replicates | treatment | Publication | Abbreviation |
---|---|---|---|---|---|---|
PRJNA605646 | RNA-Seq | Naïve H9 ESC | 2 | Naive human PSC condition | Io et al. | nH9_Io |
PRJNA605646 | RNA-Seq | Naïve H9 ESC-derived nTE_D1 | 2 | ABPJ treatment for 1 day | Io et al. | H9_nTE_D1_Io |
PRJNA605646 | RNA-Seq | Naïve H9 ESC-derived nTE_D2 | 2 | ABPJ treatment for 2 days | Io et al. | H9_nTE_D2_Io |
PRJNA605646 | RNA-Seq | term Amnion (Cont2,3,4,4b,6,7,8,9,11,12,14,15 RNA-seq) | 2 | ABPJ treatment for 3 days | Io et al. | H9_nTE_D3_Io |
PRJNA605646 | RNA-Seq | Naïve H9 ESC-derived nCT_P3 | 2 | ACE treatment | Io et al. | H9_nCT_P3_Io |
PRJNA605646 | RNA-Seq | Naïve H9 ESC-derived nCT_P10 | 2 | ACE treatment | Io et al. | H9_nCT_P10_Io |
PRJNA605646 | RNA-Seq | Naïve H9 ESC-derived nCT_P15 | 2 | ACE treatment | Io et al. | H9_nCT_P15_Io |
PRJNA605646 | RNA-Seq | Naïve PSC (Guo et al. Development 2017)-derived nCT_P15 | 2 | ACE treatment | Io et al. | cR_nCT_P15_Io |
PRJNA605646 | RNA-Seq | 409B2 hiPSC-derived nCT_P15 | 2 | ACE treatment | Io et al. | iPS_nCT_P15_Io |
PRJNA605646 | RNA-Seq | 1st Trimester_TSC (Okae et al) (CT30) | 2 | Okae et al. Cell Stem Cell 2018 | Io et al. | CT_TSC_Okae |
PRJNA605646 | RNA-Seq | nST from Naïve H9 ESC-derived nCT | 2 | modified from Okae et al. Cell Stem Cell 2018 | Io et al. | H9_nSCT_Io |
PRJNA605646 | RNA-Seq | nEVT from Naïve H9 ESC-derived nCT | 2 | modified from Okae et al. Cell Stem Cell 2018 | Io et al. | H9_nEVT_Io |
PRJNA605646 | RNA-Seq | Primed H9 ESC | 2 | primed human PSC condition | Io et al. | pH9_Io |
PRJNA605646 | RNA-Seq | pBAP_D1 from Primed H9 ESC | 2 | MEF-CM with BAP treatment | Io et al. | H9_pBAP_D1_Io |
PRJNA605646 | RNA-Seq | pBAP_D2 from Primed H9 ESC | 2 | MEF-CM with BAP treatment | Io et al. | H9_pBAP_D2_Io |
PRJNA605646 | RNA-Seq | pBAP_D3 from Primed H9 ESC | 2 | MEF-CM with BAP treatment | Io et al. | H9_pBAP_D3_Io |
PRJNA605646 | RNA-Seq | Cytotrophoblast at 7 gestational weeks | 2 | 7 gestational weeks | Io et al. | CT_7wk |
PRJNA605646 | RNA-Seq | Cytotrophoblast at 9 gestational weeks | 1 | 9 gestational weeks | Io et al. | CT_9wk |
PRJNA605646 | RNA-Seq | Cytotrophoblast at 11 gestational weeks | 1 | 11 gestational weeks | Io et al. | CT_11wk |
PRJNA294733 | RNA-Seq | H1 ESC-derived TB_BAP D8 (large cells, >70 μm) | 3 | BAP treatment | Yabe et al. | H1_BAP_D8_>70_Yabe |
PRJNA294733 | RNA-Seq | H1 ESC-derived TB_BAP D8 (between 40-70 μm) | 3 | BAP treatment | Yabe et al. | H1_BAP_D8_40-70_Yabe |
PRJNA294733 | RNA-Seq | H1 ESC-derived TB_BAP D8 (small cells, <40 μm) | 3 | BAP treatment | Yabe et al. | H1_BAP_D8_<40_Yabe |
PRJNA294733 | RNA-Seq | undifferentiated H1 ESC | 3 | MEF-CM with FGF2 treatment | Yabe et al. | H1_Yabe |
E-MTAB-10429 | RNA-Seq | Blastocyst_TSC (Okae et al) (BTS5, BTS11) | 2 | Okae et al. Cell Stem Cell 2018 | Sheridan et al. | BTS_TSC_Okae |
E-MTAB-10429 | RNA-Seq | 1st Trimester_TSC (Okae et al) (CT27, CT29, CT30) | 3 | Okae et al. Cell Stem Cell 2018 | Sheridan et al. | CT_TSC_Okae |
E-MTAB-10429 | RNA-Seq | Blastocyst_EVT (Okae et al) (BTS5, BTS11) | 2 | Okae et al. Cell Stem Cell 2018 | Sheridan et al. | BTS_EVT_Okae |
E-MTAB-10429 | RNA-Seq | 1st Trimester_EVT (Okae et al) (CT27, CT29, CT30) | 3 | Okae et al. Cell Stem Cell 2018 | Sheridan et al. | CT_EVT_Okae |
E-MTAB-10429 | RNA-Seq | Blastocyst_SCT (Okae et al) (BTS5, BTS11) | 2 | Okae et al. Cell Stem Cell 2018 | Sheridan et al. | BTS_SCT_Okae |
E-MTAB-10429 | RNA-Seq | 1st Trimester_TSC (Okae et al) (CT27, CT29, CT30) | 3 | Okae et al. Cell Stem Cell 2018 | Sheridan et al. | CT_SCT_Okae |
E-MTAB-10429 | RNA-Seq | Organoid_villous (Turco et al) (R053, X011, X021,X035) | 4 | Turco et al. Nature 2018 | Sheridan et al. | org_villous |
E-MTAB-10429 | RNA-Seq | Organoid_EVT (Turco et al) (R053, X011, X021, x035) | 4 | Turco et al. Nature 2018 | Sheridan et al. | org_EVT |
PRJNA414247 | RNA-Seq | undifferentiated hESC line H9 cells | 2 | untreated | Krendl et al. | H9_Krendl |
PRJNA414247 | RNA-Seq | hESC line H9 cells after 8 hours of BMP4 treatment | 2 | BMP4 exposed H9 cells | Krendl et al. | H9_BMP4_8h_Krendl |
PRJNA414247 | RNA-Seq | hESC line H9 cells after 16 hours of BMP4 treatment | 2 | BMP4 exposed H9 cells | Krendl et al. | H9_BMP4_16h_Krendl |
PRJNA414247 | RNA-Seq | hESC line H9 cells after 24 hours of BMP4 treatment | 2 | BMP4 exposed H9 cells | Krendl et al. | H9_BMP4_D1_Krendl |
PRJNA414247 | RNA-Seq | hESC line H9 cells after 48 hours of BMP4 treatment | 2 | BMP4 exposed H9 cells | Krendl et al. | H9_BMP4_D2_Krendl |
PRJNA414247 | RNA-Seq | hESC line H9 cells after 72 hours of BMP4 treatment | 2 | BMP4 exposed H9 cells | Krendl et al. | H9_BMP4_D3_Krendl |
PRJNA352339 | RNA-Seq | undifferentiated H9 ESC, feeder free | 3 | mTeSR | Shao et al. | H9_ESC_Shao |
PRJNA352339 | RNA-Seq | H9 ESC-derived amnion-like cells (3D amniogenesis) | 3 | Shao et al. Nature Mater 2017 | Shao et al. | H9_amnion_Shao |
PRJNA276463 | RNA-Seq | CC2 Amnion_18_female | 1 | 18 gestational weeks | Roost et al. | amnion_18wk |
PRJNA276463 | RNA-Seq | CJ1 Amnion_9_male | 2 | 9 gestational weeks | Roost et al. | amnion_9wk |
PRJNA276463 | RNA-Seq | CI1 Amnion_16_male | 2 | 16 gestational weeks | Roost et al. | amnion_16wk |
PRJNA276463 | RNA-Seq | CR1 Amnion_22_male | 2 | 22 gestational weeks | Roost et al. | amnion_22wk |
PRJNA316992 | RNA-Seq | Term Amnion (Cont2,3,4,4b,6,7,8,9,11,12,14,15 RNA-seq) | 12 | Term fetal amnion | Suzuki et al. | amnion_term |
PRJNA720858 | snRNA-Seq | H1 ESC-derived TB_BAP D8 (20% O2)_snRNA-seq | 2 | BAP treatment | Khan et al. | H1_BAP_D8_20pcO2_Khan |
PRJNA720858 | snRNA-Seq | H1 ESC-derived TB_BAP D8 (5% O2)_snRNA-seq | 2 | BAP treatment | Khan et al. | H1_BAP_D8_5pcO2_Khan |
PRJNA705594 | scRNA-Seq | Naïve H9 ESC-derived nTE_D2 | 1 | ABPJ treatment | Io et al. | H9_sc.nTE_D2_Io |
PRJNA705594 | scRNA-Seq | Naïve H9 ESC-derived nTE_D3 | 1 | ABPJ treatment | Io et al. | H9_sc.nTE_D3_Io |
PRJNA705594 | scRNA-Seq | Naïve H9 ESC-derived nCT_D5 | 1 | ACE treatment | Io et al. | H9_sc.nCT_D5_Io |
PRJNA705594 | scRNA-Seq | Naïve H9 ESC-derived nCT_D10 | 1 | ACE treatment | Io et al. | H9_sc.nCT_D10_Io |
Syncytiotrophoblast (STB) genes expression were tested against Zhou et. al., dataset (GSE109555).
Custom PlacentaCellEnrich were generated using: Xiang et. al.(NCBI BioProject: PRJNA562548 and Castel et al. publication, using data from Petropoulos et al., and Zhou et al., downloaded from BitBucket
- Project related questions: Geetu Tuteja
- Scripts and workflow related questions: please open an issue here on GitHub.
If you use the scripts from this repository in your research, please cite this publication:
Seetharam, Arun S., Ha TH Vu, Sehee Choi, Teka Khan, Megan A. Sheridan, Toshihiko Ezashi, R. Michael Roberts, and Geetu Tuteja. "The product of BMP-directed differentiation protocols for human primed pluripotent stem cells is placental trophoblast and not amnion." Stem Cell Reports (2022). Available online 19 May 2022.